
  
    
      
        Introduction_NNP
        Asthma_NNP is_VBZ a_DT common_JJ condition_NN in_IN general_JJ medical_JJ
        practice_NN ,_, accounting_NN for_IN about_IN 1_CD %_NN of_IN all_DT ambulatory_JJ visits_NNS
        in_IN the_DT USA_NNP [_NN 1_CD ]_NN ._. The_DT mortality_NN rate_NN from_IN asthma_NN has_VBZ risen_VBN
        sharply_RB since_IN the_DT late_JJ 1970_CD s_VBZ ,_, which_WDT may_MD reflect_VB increasing_VBG
        disease_NN severity_NN [_NN 2_CD ]_NN ._. The_DT hospitalization_NN rate_NN ,_, another_DT
        population-level_JJ marker_NN of_IN asthma_NN severity_NN ,_, remains_VBZ
        substantial_JJ [_NN 2_CD ]_NN ,_, generating_NN nearly_RB one-half_NN of_IN all_DT US_NNP
        health_NN care_NN costs_NNS for_IN asthma_NN [_NN 3_CD ]_NN ._. Hospitalization_NNP rates_NNS
        for_IN asthma_NN have_VBP actually_RB increased_VBN in_IN some_DT demographic_JJ
        subgroups_NNS ,_, such_JJ as_IN young_JJ adults_NNS [_NN 2_CD ]_NN and_CC the_DT urban_JJ poor_JJ [_NN
        4_CD ]_NN ,_, despite_IN recent_JJ therapeutic_JJ advances_NNS ._. Understanding_NNP the_DT
        factors_NNS underlying_VBG hospitalization_NN for_IN asthma_NN could_MD help_VB
        elucidate_NN the_DT recent_JJ rise_NN in_IN asthma_NN morbidity_NN ._.
        Previous_JJ studies_NNS have_VBP identified_VBN several_JJ factors_NNS that_WDT
        contribute_VBP to_TO increased_VB hospitalization_NN risk_NN among_IN adults_NNS
        with_IN asthma_NN ._. Demographic_NNP characteristics_NNS ,_, such_JJ as_IN poverty_NN ,_,
        low_JJ educational_JJ attainment_NN ,_, female_JJ gender_NN ,_, and_CC
        African-_NNP American_JJ race_NN ,_, have_VBP been_VBN associated_VBN with_IN a_DT greater_JJR
        risk_NN of_IN hospitalization_NN for_IN asthma_NN [_NN 2_CD ,_, 4_CD ,_, 5_CD ,_, 6_CD ,_, 7_CD ,_, 8_CD ,_, 9_CD ,_,
        10_CD ,_, 11_CD ]_NN ._. Poor_JJ health_NN care_NN access_NN and_CC inadequate_JJ preventive_JJ
        asthma_NN care_NN have_VBP also_RB been_VBN frequently_RB cited_VBN as_IN contributing_VBG
        factors_NNS [_NN 5_CD ,_, 12_CD ,_, 13_CD ,_, 14_CD ,_, 15_CD ]_NN ._. In_IN these_DT studies_NNS ,_, however_RB ,_,
        separating_VBG the_DT independent_JJ effects_NNS of_IN demographic_JJ
        characteristics_NNS ,_, health_NN care_NN access_NN ,_, and_CC disease_NN severity_NN
        has_VBZ been_VBN difficult_JJ ._. For_IN instance_NN ,_, the_DT association_NN between_IN
        low_JJ income_NN or_CC non-white_JJ race_NN and_CC greater_JJR asthma_NN
        hospitalization_NN risk_NN is_VBZ potentially_RB confounded_JJ by_IN
        inadequate_JJ health_NN care_NN access_NN ._. Because_IN many_JJ studies_NNS rely_VBP on_IN
        ecologic_JJ socioeconomic_JJ and_CC hospitalization_NN data_NNS ,_,
        individual-level_JJ factors_NNS -_: especially_RB asthma_NN severity_NN -_:
        cannot_NN be_VB adequately_RB examined_VBN [_NN 4_CD ,_, 5_CD ,_, 6_CD ,_, 7_CD ,_, 8_CD ,_, 15_CD ,_, 16_CD ,_, 17_CD ,_,
        18_CD ]_NN ._. Other_JJ studies_NNS have_VBP not_RB yet_RB provided_VBN prospective_JJ
        follow-up_JJ [_NN 9_CD ,_, 10_CD ,_, 19_CD ,_, 20_CD ]_NN or_CC have_VBP not_RB simultaneously_RB
        considered_VBN both_DT demographic_JJ and_CC clinical_JJ variables_NNS [_NN 21_CD ,_,
        22_CD ]_NN ._.
        In_IN this_DT article_NN ,_, using_VBG a_DT prospective_JJ cohort_NN study_NN of_IN
        adults_NNS with_IN asthma_NN ,_, we_PRP delineate_NN the_DT relative_JJ impact_NN of_IN
        demographic_JJ characteristics_NNS and_CC asthma_NN severity_NN on_IN
        subsequent_JJ hospitalization_NN for_IN asthma_NN ._. Since_IN study_NN subjects_NNS
        were_VBD recruited_VBN from_IN a_DT random_JJ sample_NN of_IN physician_NN practices_NNS ,_,
        they_PRP all_DT had_VBN access_NN to_TO health_NN care_NN for_IN asthma_NN ._. As_IN a_DT result_NN ,_,
        we_PRP could_MD evaluate_VB the_DT effects_NNS of_IN gender_NN ,_, race_NN ,_, income_NN ,_, and_CC
        asthma_NN severity_NN on_IN hospitalization_NN ,_, independent_JJ of_IN health_NN
        care_NN access_NN ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Subject_NNP recruitment_NN and_CC retention_NN
          We_PRP used_VBD data_NNS collected_VBN during_IN a_DT prospective_JJ ,_,
          longitudinal_NN cohort_NN study_NN of_IN adults_NNS with_IN asthma_NN recruited_VBN
          from_IN physician_NN practices_NNS in_IN Northern_NNP California_NNP ._. Details_NNS
          of_IN the_DT study_NN design_NN have_VBP been_VBN previously_RB reported_VBN [_NN 23_CD ,_,
          24_CD ,_, 25_CD ,_, 26_CD ]_NN ._. Each_DT subject_NN underwent_VBD a_DT structured_VBN ,_,
          computer-assisted_JJ telephone_NN interview_NN covering_VBG
          demographic_JJ characteristics_NNS ,_, smoking_NN history_NN ,_, asthma_NN
          history_NN ,_, symptoms_NNS ,_, and_CC treatment_NN ,_, health_NN status_NN ,_, health_NN
          care_NN utilization_NN for_IN asthma_NN ,_, and_CC insurance_NN for_IN asthma_NN
          care_NN ._.
          Physicians_NNPS registered_VBD 669_CD eligible_JJ patients_NNS ._. After_IN
          initial_JJ data_NNS collection_NN at_IN baseline_NN (_( 
          n_NN =_SYM 601_CD )_) and_CC 18_CD -_: month_NN follow-up_JJ
          interviews_NNS (_( 
          n_NN =_SYM 539_CD )_) ,_, we_PRP later_RB restricted_VBD the_DT
          data_NNS set_VBN to_TO 371_CD of_IN the_DT baseline_NN cohort_NN (_( 55_CD %_NN of_IN total_JJ
          registry_NN )_) and_CC 242_CD of_IN the_DT follow-up_JJ subjects_NNS (_( 65_CD %_NN of_IN
          restricted_VBN baseline_NN cohort_NN )_) ._. We_PRP restricted_VBD the_DT data_NNS set_VBN
          to_TO eliminate_VB all_DT interviews_NNS potentially_RB compromised_VBN by_IN
          faulty_JJ data_NNS collection_NN or_CC documentation_NN by_IN a_DT single_JJ
          survey_NN interviewer_NN [_NN 26_CD ,_, 27_CD ]_NN ._. This_DT restricted_VBN data_NN set_VBN
          excluded_VBN 24_CD baseline_NN subjects_NNS who_WP were_VBD found_VBN to_TO be_VB
          outside_IN the_DT study_NN age_NN range_NN and_CC 206_CD baseline_NN subjects_NNS
          with_IN inconsistent_JJ data_NNS during_IN subsequent_JJ re-interview_JJ ._. Of_IN
          the_DT 371_CD baseline_NN subjects_NNS ,_, the_DT present_JJ study_NN excludes_VBZ an_DT
          additional_JJ 129_CD subjects_NNS at_IN 18_CD -_: month_NN follow-up_JJ interview_NN
          who_WP had_VBD inconsistent_JJ data_NNS at_IN later_JJ interviews_NNS or_CC did_VBD not_RB
          complete_JJ follow-up_JJ ,_, leaving_VBG 242_CD follow-up_JJ interviews_NNS (_( 18_CD
          month_NN )_) ._. These_DT exclusions_NNS had_VBD no_DT significant_JJ effect_NN on_IN
          study_NN findings_NNS ._.
          Demographic_NNP data_NNS for_IN comparison_NN of_IN the_DT baseline_NN cohort_NN
          (_( 
          n_NN =_SYM 371_CD )_) with_IN registered_VBN subjects_NNS (_(
          
          n_NN =_SYM 669_CD )_) are_VBP not_RB available_JJ ._.
          Compared_VBN with_IN subjects_NNS who_WP participated_VBD in_IN both_DT baseline_NN
          and_CC follow-up_JJ interviews_NNS (_( 
          n_NN =_SYM 242_CD )_) ,_, subjects_NNS without_IN complete_JJ
          follow-up_JJ interviews_NNS (_( 
          n_NN =_SYM 129_CD )_) were_VBD younger_JJR (_( 36_CD ._. 6_CD years_NNS
          versus_CC 40_CD ._. 5_LS years_NNS )_) and_CC less_RBR likely_JJ to_TO have_VB white_JJ
          race_NN /_NN ethnicity_NN (_( 62_CD %_NN versus_CC 71_CD %_NN ;_: 
          P_NN <_NN 0_CD ._. 001_CD and_CC 
          P_NN =_SYM 0_CD ._. 10_CD ,_, respectively_RB )_) ._. There_EX were_VBD
          no_DT statistical_JJ differences_NNS in_IN history_NN of_IN ever_RB smoking_VBG
          (_( 43_CD %_NN of_IN participants_NNS in_IN both_DT interviews_NNS versus_CC 37_CD %_NN of_IN
          non-participants_JJ at_IN follow-up_JJ )_) ,_, female_JJ gender_NN (_( 73_CD %_NN versus_CC
          66_CD %_NN )_) ,_, atopic_JJ history_NN (_( 82_CD %_NN versus_CC 83_CD %_NN )_) ,_, or_CC
          severity-of-asthma_JJ scores_NNS (_( 11_CD ._. 0_CD versus_CC 10_CD ._. 6_CD ;_: 
          P_NN >_NN 0_CD ._. 15_CD in_IN all_DT cases_NNS )_) ._.
        
        
          Hospitalization_NNP for_IN asthma_NN
          The_DT primary_JJ study_NN outcome_NN was_VBD self-reported_JJ
          hospitalization_NN for_IN asthma_NN during_IN the_DT 18_CD -_: month_NN
          prospective_JJ follow-up_JJ period_NN ._. Subjects_NNP were_VBD asked_VBN at_IN
          18_CD -_: month_NN follow-up_JJ interviews_NNS whether_IN they_PRP had_VBD been_VBN
          hospitalized_VBN for_IN asthma_NN during_IN the_DT previous_JJ 18_CD months_NNS ._.
          Although_IN subjects_NNS could_MD indicate_VB more_JJR than_IN one_CD positive_JJ
          response_NN ,_, we_PRP analyzed_VBD the_DT binary_JJ outcome_NN of_IN one_CD or_CC more_JJR
          hospitalization_NN for_IN asthma_NN ._.
        
        
          Risk_NN factor_NN variables_NNS
          All_DT demographic_JJ variables_NNS were_VBD based_VBN on_IN baseline_NN
          subject_JJ interview_NN responses_NNS ._. Current_JJ and_CC prior_RB cigarette_NN
          smoking_NN history_NN was_VBD assessed_VBN using_VBG questions_NNS adapted_VBN from_IN
          the_DT National_NNP Health_NNP Interview_NNP Survey_NNP [_NN 28_CD ]_NN ._.
          We_PRP previously_RB developed_VBD and_CC validated_JJ a_DT 13_CD -_: item_NN
          disease-specific_JJ severity-of-asthma_JJ score_NN with_IN four_CD
          subscales_NNS :_: frequency_NN of_IN current_JJ asthma_NN symptoms_NNS (_( daytime_JJ
          or_CC nocturnal_NN )_) ,_, use_NN of_IN systemic_JJ corticosteroids_NNS ,_, use_NN of_IN
          other_JJ asthma_NN medications_NNS (_( besides_IN systemic_JJ
          corticosteroids_NNS )_) ,_, and_CC history_NN of_IN hospitalizations_NNS and_CC
          intubations_NNS [_NN 23_CD ,_, 24_CD ,_, 25_CD ]_NN ._. Possible_JJ total_JJ scores_NNS range_VBP
          from_IN 0_CD to_TO 28_CD ,_, with_IN higher_JJR scores_NNS reflecting_VBG more_RBR severe_JJ
          asthma_NN ._. To_TO examine_VB the_DT relative_JJ impact_NN of_IN recent_JJ and_CC
          remote_JJ hospitalization_NN on_IN further_JJ hospitalization_NN for_IN
          asthma_NN over_IN longitudinal_NN follow-up_JJ ,_, we_PRP removed_VBD
          hospitalization_NN from_IN the_DT established_VBN severity_NN score_NN and_CC
          defined_VBN two_CD new_JJ variables_NNS :_: recent_JJ hospitalization_NN (_( during_IN
          the_DT 12_CD months_NNS prior_RB to_TO baseline_NN interview_NN )_) ,_, or_CC remote_JJ
          hospitalization_NN (_( past_JJ hospitalization_NN not_RB meeting_VBG the_DT
          previous_JJ definition_NN of_IN recent_JJ )_) ._. As_IN a_DT result_NN ,_, the_DT
          hospitalization_NN and_CC intubation_NN subscale_NN now_RB reflects_VBZ only_RB
          prior_RB history_NN of_IN intubation_NN ._.
          Several_JJ other_JJ clinical_JJ aspects_NNS of_IN asthma_NN were_VBD
          assessed_VBN ._. We_PRP defined_VBD asthma_NN onset_NN as_IN the_DT subject-reported_JJ
          age_NN of_IN first_JJ asthma_NN symptoms_NNS ._. Atopic_NNP history_NN was_VBD defined_VBN
          by_IN a_DT reported_VBN history_NN of_IN allergic_JJ rhinitis_NNS or_CC atopic_JJ
          dermatitis_NNS ._. Because_IN prior_JJ work_NN suggests_VBZ an_DT unexpectedly_RB
          high_JJ prevalence_NN of_IN aspirin_NN intolerance_NN in_IN persons_NNS with_IN
          near_IN fatal_JJ asthma_NN [_NN 29_CD ]_NN ,_, we_PRP ascertained_JJ any_DT history_NN of_IN
          aspirin_NN sensitivity_NN at_IN baseline_NN interview_NN ._. Since_IN
          gastroesophageal_NN reflux_NN disease_NN (_( GERD_NNP )_) may_MD exacerbate_VB
          asthma_NN symptoms_NNS [_NN 30_CD ]_NN ,_, we_PRP evaluated_VBD whether_IN subjects_NNS were_VBD
          taking_VBG H_NNP 2_CD -_: blockers_NNS or_CC proton_NN pump_NN inhibitors_NNS as_IN
          surrogates_NNS for_IN GERD_NNP and_CC related_VBN conditions_NNS ._. We_PRP
          furthermore_RB determined_VBD whether_IN subjects_NNS possessed_VBD a_DT peak_NN
          flow_NN meter_NN for_IN home_NN usage_NN ._.
          Generic_NNP health_NN status_NN was_VBD measured_VBN using_VBG the_DT Medical_NNP
          Outcomes_NNP Study_NNP SF-_NNP 36_CD questionnaire_NN [_NN 31_CD ,_, 32_CD ]_NN ._. We_PRP assessed_VBD
          several_JJ indicators_NNS of_IN health_NN care_NN access_NN for_IN asthma_NN care_NN ,_,
          including_VBG whether_IN subjects_NNS had_VBD a_DT regular_JJ site_NN for_IN asthma_NN
          care_NN ,_, a_DT principal_JJ care_NN provider_NN for_IN asthma_NN ,_, medical_JJ
          insurance_NN for_IN outpatient_NN asthma_NN care_NN ,_, and_CC an_DT annual_JJ
          deduction_NN for_IN outpatient_NN medical_JJ care_NN ._. We_PRP also_RB identified_VBD
          subjects_NNS who_WP appeared_VBD to_TO rely_VB on_IN emergency_NN department_NN
          (_( ED_NNP )_) services_NNS for_IN urgent_JJ asthma_NN care_NN ._. We_PRP defined_VBD reliance_NN
          on_IN ED_NNP care_NN as_IN one_CD or_CC more_RBR self-reported_JJ ED_NNP visits_NNS during_IN
          the_DT interview_NN interval_NN but_CC no_DT urgent_JJ outpatient_NN clinic_NN or_CC
          office_NN visits_NNS for_IN asthma_NN ,_, either_CC to_TO regular_JJ or_CC alternate_JJ
          sources_NNS of_IN asthma_NN care_NN ._.
        
        
          Statistical_NNP analysis_NN
          In_IN a_DT previous_JJ analysis_NN of_IN pulmonary_JJ and_CC allergy_NN
          specialist_NN care_NN ,_, the_DT severity-of-asthma_JJ score_NN was_VBD
          associated_VBN with_IN an_DT increased_VBN risk_NN of_IN hospitalization_NN at_IN
          18_CD -_: month_NN follow-up_JJ [_NN 25_CD ]_NN ._. The_DT current_JJ study_NN evaluates_VBZ
          other_JJ risk_NN factors_NNS for_IN asthma-related_JJ hospitalization_NN ,_,
          taking_VBG baseline_NN asthma_NN severity_NN into_IN account_NN ._. Because_IN
          asthma_NN severity_NN may_MD act_VB on_IN the_DT causal_NN pathway_NN between_IN a_DT
          risk_NN factor_NN and_CC subsequent_JJ hospitalization_NN for_IN asthma_NN ,_, we_PRP
          present_JJ multivariate_NN models_NNS both_DT including_VBG and_CC excluding_VBG
          baseline_NN asthma_NN severity_NN and_CC generic_JJ health_NN status_NN ._. For_IN
          example_NN ,_, low_JJ education_NN could_MD increase_VB the_DT risk_NN of_IN
          hospitalization_NN either_DT directly_RB ,_, through_IN poor_JJ
          self-management_JJ strategies_NNS ,_, or_CC indirectly_RB ,_, if_IN poorly_RB
          educated_VBN persons_NNS have_VBP greater_JJR asthma_NN severity_NN for_IN other_JJ
          reasons_NNS ._. We_PRP also_RB delineate_NN the_DT components_NNS of_IN asthma_NN
          severity_NN -_: respiratory_JJ symptoms_NNS ,_, systemic_JJ corticosteroid_NN
          use_NN ,_, other_JJ asthma_NN medication_NN use_NN ,_, past_JJ intubations_NNS ,_, and_CC
          previous_JJ hospitalizations_NNS -_: that_WDT are_VBP most_RBS strongly_RB
          predictive_JJ of_IN subsequent_JJ hospitalization_NN ._.
          Interview_NNP data_NNS were_VBD analyzed_VBN using_VBG SAS_NNP 6_CD ._. 12_CD software_NN
          (_( SAS_NNP Institute_NNP ,_, Cary_NNP ,_, NC_NNP ,_, USA_NNP )_) ._. We_PRP evaluated_VBD the_DT
          association_NN between_IN baseline_NN characteristics_NNS and_CC the_DT risk_NN
          of_IN hospitalization_NN for_IN asthma_NN during_IN the_DT ensuing_VBG 18_CD -_: month_NN
          follow-up_JJ period_NN ,_, reported_VBD at_IN the_DT 18_CD -_: month_NN interview_NN ._. We_PRP
          use_VBP the_DT data_NNS set_VBN restricted_VBN to_TO 242_CD subjects_NNS with_IN verified_VBN
          baseline_NN and_CC follow-up_JJ interviews_NNS for_IN all_DT analyses_NNS ._.
          Bivariate_NNP relationships_NNS were_VBD examined_VBN using_VBG logistic_JJ
          regression_NN analysis_NN ,_, with_IN separate_JJ models_NNS for_IN each_DT
          predictor_NN variable_JJ ._. We_PRP used_VBD multiple_JJ logistic_JJ regression_NN
          analysis_NN to_TO elucidate_NN the_DT independent_JJ association_NN between_IN
          each_DT baseline_NN variable_JJ and_CC the_DT prospective_JJ risk_NN of_IN
          hospitalization_NN ._. In_IN constructing_VBG the_DT multivariate_NN model_NN ,_,
          all_DT predictor_NN variables_NNS whose_WP$ bivariate_NN odds_NNS ratio_NN and_CC
          95_CD %_NN confidence_NN interval_NN suggested_VBD a_DT possible_JJ association_NN
          with_IN hospitalization_NN were_VBD entered_VBN into_IN the_DT final_JJ model_NN ._.
          All_DT variables_NNS deemed_VBD important_JJ on_IN an_DT a_DT priori_FW basis_NN ,_, such_JJ
          as_IN age_NN ,_, were_VBD also_RB included_VBN ._.
        
      
      
        Results_NNS
        
          Health_NN care_NN access_NN
          Reflecting_VBG the_DT sampling_VBG method_NN employed_VBN ,_, all_DT subjects_NNS
          identified_VBD a_DT regular_JJ source_NN of_IN asthma_NN care_NN and_CC a_DT primary_JJ
          medical_JJ provider_NN for_IN asthma_NN care_NN at_IN baseline_NN interview_NN ._.
          The_DT majority_NN of_IN participants_NNS (_( 97_CD %_NN )_) also_RB reported_VBD having_VBG
          health_NN insurance_NN covering_VBG outpatient_NN visits_NNS for_IN asthma_NN ._.
          Approximately_RB one-third_NN of_IN subjects_NNS indicated_VBD having_VBG
          annual_JJ insurance_NN deductible_JJ for_IN physician_NN visits_NNS (_( 31_CD %_NN )_) ._.
          The_DT majority_NN of_IN subjects_NNS continued_VBD to_TO report_VB health_NN
          insurance_NN coverage_NN (_( 96_CD %_NN )_) and_CC ongoing_JJ primary_JJ asthma_NN care_NN
          (_( 99_CD %_NN )_) at_IN 18_CD -_: month_NN follow-up_JJ ._. Despite_IN apparent_JJ access_NN to_TO
          outpatient_NN medical_JJ care_NN ,_, a_DT substantial_JJ proportion_NN (_( 16_CD %_NN )_)
          appeared_VBD to_TO rely_VB on_IN the_DT ED_NNP for_IN urgent_JJ asthma_NN care_NN ._.
        
        
          Demographic_NNP factors_NNS and_CC the_DT risk_NN of_IN
          hospitalization_NN :_: bivariate_NN analysis_NN
          Table_NNP 1_CD shows_VBZ that_IN the_DT mean_JJ baseline_NN age_NN was_VBD 40_CD ._. 5_LS years_NNS
          and_CC the_DT majority_NN of_IN subjects_NNS were_VBD female_JJ (_( 73_CD %_NN )_) ._. A_DT
          substantial_JJ proportion_NN reported_VBD ever_RB smoking_NN cigarettes_NNS
          (_( 43_CD %_NN )_) ,_, with_IN fewer_JJR indicating_VBG current_JJ smoking_NN (_( 7_CD %_NN )_) ._. The_DT
          majority_NN of_IN subjects_NNS indicated_VBD white_JJ ,_, non-_NN Hispanic_JJ
          race_NN /_NN ethnicity_NN (_( 71_CD %_NN )_) ._.
          Thirty-nine_NNP subjects_NNS (_( 16_CD %_NN )_) reported_VBD at_IN least_JJS one_CD
          hospitalization_NN for_IN asthma_NN during_IN the_DT prospective_JJ
          18_CD -_: month_NN follow-up_JJ period_NN ._. Of_IN the_DT baseline_NN
          characteristics_NNS ,_, non-white_JJ race_NN (_( OR_NNP ,_, 2_CD ._. 1_CD ;_: 95_CD %_NN CI_NNP ,_,
          1_CD ._. 1_CD -_: 4_CD ._. 0_CD )_) and_CC lower_JJR income_NN (_( OR_NNP ,_, 1_CD ._. 3_CD ;_: 95_CD %_NN CI_NNP ,_, 1_CD ._. 1_CD -_: 1_CD ._. 5_LS )_) were_VBD
          associated_VBN with_IN a_DT greater_JJR risk_NN of_IN hospitalization_NN for_IN
          asthma_NN during_IN the_DT 18_CD -_: month_NN follow-up_JJ (_( Table_NNP 1_LS )_) ._. Current_JJ
          smokers_NNS had_VBD an_DT increased_VBN likelihood_NN of_IN hospitalization_NN ,_,
          although_IN the_DT confidence_NN interval_NN did_VBD not_RB exclude_VB no_DT
          association_NN ._. Greater_NNP educational_JJ attainment_NN was_VBD related_VBN
          to_TO a_DT lower_JJR risk_NN of_IN hospitalization_NN (_( OR_NNP ,_, 0_CD ._. 8_CD per_IN year_NN of_IN
          education_NN ;_: 95_CD %_NN CI_NNP ,_, 0_CD ._. 70_CD -_: 0_CD ._. 96_CD )_) ._.
        
        
          Clinical_NNP risk_NN factors_NNS for_IN hospitalization_NN :_:
          bivariate_NN analysis_NN
          A_DT greater_JJR severity-of-asthma_JJ score_NN ,_, excluding_VBG its_PRP$
          hospitalization_NN component_NN ,_, was_VBD associated_VBN with_IN a_DT higher_JJR
          risk_NN of_IN subsequent_JJ hospitalization_NN for_IN asthma_NN (_( OR_NNP ,_, 4_CD ._. 7_CD
          per_IN 5_CD -_: point_NN score_NN increment_NN ;_: 95_CD %_NN CI_NNP ,_, 2_CD ._. 9_CD -_: 7_CD ._. 7_CD )_) (_( Table_NNP 2_LS )_) ._.
          Although_IN remote_JJ asthma_NN hospitalization_NN did_VBD not_RB appear_VB
          related_VBN to_TO risk_NN of_IN ensuing_VBG hospitalization_NN ,_, more_RBR recent_JJ
          hospitalization_NN was_VBD strongly_RB associated_VBN with_IN increased_VBN
          risk_NN (_( OR_NNP ,_, 11_CD ._. 6_CD ;_: 95_CD %_NN CI_NNP ,_, 5_CD ._. 3_CD -_: 25_CD ._. 2_LS )_) ._. Other_JJ clinical_JJ
          variables_NNS that_WDT may_MD reflect_VB exacerbating_VBG factors_NNS ,_, such_JJ as_IN
          aspirin_NN allergy_NN and_CC use_NN of_IN gastric_JJ acid_NN suppression_NN
          medication_NN ,_, were_VBD also_RB associated_VBN with_IN a_DT greater_JJR risk_NN of_IN
          asthma_NN hospitalization_NN ._.
          Better_NNP baseline_NN generic_JJ physical_JJ health_NN status_NN (_( SF-_NNP 36_CD )_)
          was_VBD associated_VBN with_IN a_DT slightly_RB decreased_VBN risk_NN of_IN
          subsequent_JJ hospitalization_NN (_( 6_CD %_NN reduction_NN in_IN odds_NNS per_IN 1_CD
          point_NN score_NN increment_NN ;_: 95_CD %_NN CI_NNP ,_, 3_CD -_: 9_CD %_NN )_) (_( Table_NNP 2_LS )_) ._. Mental_NNP
          health_NN status_NN was_VBD furthermore_RB associated_VBN with_IN a_DT 4_CD %_NN
          reduction_NN in_IN the_DT risk_NN of_IN hospitalization_NN per_IN 1_CD point_NN (_( 95_CD %_NN
          CI_NNP ,_, 0_CD -_: 7_CD %_NN )_) ._. Reliance_NNP on_IN emergency_NN department_NN care_NN was_VBD
          finally_RB related_VBN to_TO a_DT greater_JJR risk_NN of_IN hospitalization_NN (_( OR_NNP ,_,
          2_CD ._. 5_CD ;_: 95_CD %_NN CI_NNP ,_, 1_CD ._. 1_CD -_: 5_CD ._. 5_LS )_) ._.
        
        
          Risk_NN of_IN hospitalization_NN -_: multivariate_NN
          analysis_NN
          We_PRP examined_VBD the_DT independent_JJ impact_NN of_IN selected_VBN
          covariates_NNS on_IN the_DT prospective_JJ risk_NN of_IN hospitalization_NN for_IN
          asthma_NN using_VBG multiple_JJ logistic_JJ regression_NN analysis_NN (_( Table_NNP
          3_LS )_) ._. Of_IN the_DT demographic_JJ characteristics_NNS ,_, non-white_JJ race_NN
          was_VBD associated_VBN with_IN a_DT greater_JJR risk_NN of_IN subsequent_JJ asthma_NN
          hospitalization_NN (_( OR_NNP ,_, 3_CD ._. 1_CD ;_: 95_CD %_NN CI_NNP ,_, 1_CD ._. 1_CD -_: 8_CD ._. 8_CD )_) after_IN
          controlling_VBG for_IN asthma_NN severity_NN and_CC the_DT other_JJ covariates_NNS
          shown_VBN ._. Lower_JJR household_NN income_NN was_VBD also_RB related_VBN to_TO a_DT
          greater_JJR risk_NN of_IN hospitalization_NN (_( OR_NNP 1_CD ._. 1_CD per_IN $_$ 10_CD ,_, 000_CD
          decrement_NN )_) ,_, although_IN the_DT 95_CD %_NN confidence_NN interval_NN did_VBD not_RB
          exclude_VB no_DT relation_NN to_TO hospitalization_NN (_( 0_CD ._. 9_CD -_: 1_CD ._. 3_LS )_) ._.
          Controlling_NNP for_IN demographic_JJ and_CC other_JJ variables_NNS ,_, greater_JJR
          severity-of-asthma_JJ score_NN (_( OR_NNP ,_, 3_CD ._. 4_CD per_IN 5_CD -_: point_NN increment_NN ;_:
          95_CD %_NN CI_NNP ,_, 1_CD ._. 7_CD -_: 6_CD ._. 8_CD )_) and_CC recent_JJ hospitalization_NN for_IN asthma_NN
          (_( OR_NNP ,_, 8_CD ._. 3_CD ;_: 95_CD %_NN CI_NNP ,_, 2_CD ._. 1_CD -_: 33_CD ._. 4_LS )_) were_VBD strongly_RB associated_VBN with_IN
          an_DT increased_VBN risk_NN of_IN hospitalization_NN ._. Reliance_NNP on_IN ED_NNP for_IN
          urgent_JJ asthma_NN care_NN was_VBD also_RB related_VBN to_TO greater_JJR risk_NN ._.
          We_PRP examined_VBD the_DT relation_NN between_IN race_NN and_CC
          hospitalization_NN in_IN more_JJR detail_NN ._. African-_NNP American_JJ race_NN was_VBD
          associated_VBN with_IN an_DT increased_VBN risk_NN of_IN hospitalization_NN for_IN
          asthma_NN ,_, compared_VBN with_IN white_JJ ,_, non-_NN Hispanic_JJ persons_NNS ,_, after_IN
          controlling_VBG for_IN covariates_NNS (_( OR_NNP ,_, 10_CD ._. 2_LS ;_: 95_CD %_NN CI_NNP ,_, 1_CD ._. 8_CD -_: 58_CD ._. 4_LS )_) ._.
          Hispanic_JJ race_NN /_NN ethnicity_NN also_RB appeared_VBD related_VBN to_TO
          hospitalization_NN (_( OR_NNP ,_, 4_CD ._. 0_CD ;_: 95_CD %_NN CI_NNP ,_, 0_CD ._. 9_CD -_: 18_CD ._. 0_CD )_) ._. There_EX was_VBD no_DT
          apparent_JJ relation_NN between_IN Asian_JJ race_NN and_CC risk_NN of_IN hospital_NN
          admission_NN (_( OR_NNP ,_, 2_CD ._. 0_CD ;_: 95_CD %_NN CI_NNP ,_, 0_CD ._. 4_CD -_: 10_CD ._. 9_CD )_) ._.
          To_TO further_VB examine_VB the_DT association_NN between_IN asthma_NN
          severity_NN and_CC hospitalization_NN ,_, we_PRP repeated_VBD the_DT
          multivariate_NN analysis_NN dividing_VBG the_DT overall_JJ
          severity-of-asthma_JJ score_NN into_IN its_PRP$ four_CD subscales_NNS ._. The_DT
          systemic_JJ corticosteroid_NN score_NN (_( OR_NNP ,_, 1_CD ._. 7_CD per_IN 5_CD -_: point_NN score_NN
          increment_NN ;_: 95_CD %_NN CI_NNP ,_, 1_CD ._. 3_CD -_: 2_CD ._. 3_LS )_) and_CC recent_JJ hospitalization_NN
          for_IN asthma_NN (_( OR_NNP ,_, 9_CD ._. 7_CD ;_: 95_CD %_NN CI_NNP ,_, 2_CD ._. 2_CD -_: 43_CD ._. 0_CD )_) were_VBD significantly_RB
          associated_VBN with_IN an_DT increased_VBN risk_NN of_IN asthma_NN
          hospitalization_NN ,_, after_IN controlling_VBG for_IN covariates_NNS ._. There_EX
          was_VBD ,_, conversely_RB ,_, no_DT statistical_JJ relationship_NN between_IN
          other_JJ asthma_NN medications_NNS (_( OR_NNP ,_, 1_CD ._. 1_CD ;_: 95_CD %_NN CI_NNP ,_, 0_CD ._. 8_CD -_: 1_CD ._. 6_CD )_) or_CC
          asthma_NN symptom_NN scores_NNS (_( OR_NNP ,_, 1_CD ._. 2_CD ;_: 95_CD %_NN CI_NNP ,_, 0_CD ._. 7_CD -_: 1_CD ._. 9_CD )_) and_CC the_DT
          ensuing_VBG risk_NN of_IN hospitalization_NN ._. Systemic_NNP corticosteroid_NN
          use_NN and_CC recent_JJ asthma_NN hospitalization_NN ,_, then_RB ,_, appear_VB to_TO
          drive_VB the_DT relationship_NN between_IN asthma_NN severity_NN and_CC
          hospitalization_NN for_IN asthma_NN ._.
          Because_IN asthma_NN severity_NN could_MD act_VB as_IN a_DT causal_NN
          intermediate_JJ between_IN a_DT risk_NN factor_NN and_CC the_DT risk_NN of_IN
          hospitalization_NN ,_, we_PRP repeated_VBD the_DT multivariate_NN analysis_NN
          excluding_VBG asthma_NN severity_NN and_CC generic_JJ health_NN status_NN from_IN
          the_DT model_NN (_( Table_NNP 3_LS )_) ._. In_IN this_DT analysis_NN ,_, low_JJ income_NN was_VBD
          more_RBR strongly_RB related_VBN to_TO a_DT greater_JJR risk_NN of_IN
          hospitalization_NN for_IN asthma_NN (_( OR_NNP ,_, 1_CD ._. 2_CD ;_: 95_CD %_NN CI_NNP ,_, 1_CD ._. 02_CD -_: 1_CD ._. 4_LS )_) ._.
          Use_NN of_IN gastric_JJ acid_NN suppression_NN therapy_NN was_VBD also_RB
          associated_VBN with_IN increased_VBN risk_NN (_( OR_NNP ,_, 2_CD ._. 2_CD ;_: 95_CD %_NN CI_NNP ,_,
          1_CD ._. 0_CD -_: 4_CD ._. 9_CD )_) ._. Although_IN other_JJ point_NN estimates_NNS and_CC confidence_NN
          intervals_NNS changed_VBN slightly_RB ,_, there_EX were_VBD no_DT other_JJ notable_JJ
          changes_NNS compared_VBN with_IN the_DT model_NN controlling_VBG for_IN asthma_NN
          severity_NN ._.
          To_TO examine_VB whether_IN subjects_NNS without_IN baseline_NN health_NN
          insurance_NN coverage_NN (_( 3_CD %_NN )_) were_VBD affecting_VBG study_NN results_NNS ,_, we_PRP
          repeated_VBD the_DT multivariate_NN analysis_NN excluding_VBG these_DT
          subjects_NNS ._. Only_RB one_CD of_IN the_DT 39_CD subjects_NNS hospitalized_VBN at_IN
          follow-up_JJ had_VBD no_DT baseline_NN health_NN insurance_NN ._. There_EX was_VBD no_DT
          meaningful_JJ impact_NN on_IN the_DT results_NNS in_IN all_DT multivariate_NN
          analyses_NNS ._. For_IN example_NN ,_, the_DT estimate_NN for_IN lower_JJR income_NN in_IN
          the_DT model_NN without_IN asthma_NN severity_NN was_VBD nearly_RB unchanged_JJ
          (_( OR_NNP ,_, 1_CD ._. 2_CD ;_: 95_CD %_NN CI_NNP ,_, 1_CD ._. 03_CD -_: 1_CD ._. 4_LS )_) ._.
        
      
      
        Discussion_NNP
        Asthma-related_NNP morbidity_NN and_CC mortality_NN have_VBP risen_VBN
        sharply_RB in_IN the_DT USA_NNP since_IN the_DT late_JJ 1970_CD s_VBZ [_NN 2_CD ]_NN ._.
        Hospitalization_NNP for_IN asthma_NN ,_, a_DT potentially_RB avoidable_JJ
        outcome_NN ,_, is_VBZ an_DT important_JJ population-level_JJ marker_NN of_IN asthma_NN
        severity_NN ._. In_IN this_DT prospective_JJ study_NN of_IN adults_NNS with_IN
        continued_JJ access_NN to_TO medical_JJ care_NN for_IN asthma_NN ,_, we_PRP identified_VBD
        two_CD demographic_JJ factors_NNS (_( low_JJ income_NN and_CC non-white_JJ race_NN )_)
        that_WDT were_VBD associated_VBN with_IN a_DT greater_JJR risk_NN of_IN hospitalization_NN
        for_IN asthma_NN ._. Reliance_NNP on_IN the_DT emergency_NN department_NN for_IN urgent_JJ
        asthma_NN care_NN was_VBD also_RB associated_VBN with_IN a_DT greater_JJR risk_NN of_IN
        subsequent_JJ hospitalization_NN ._. Greater_NNP asthma_NN severity_NN ,_, as_IN
        indicated_VBN by_IN recent_JJ asthma_NN hospitalization_NN and_CC systemic_JJ
        corticosteroid_NN use_NN ,_, was_VBD related_VBN to_TO an_DT increased_VBN likelihood_NN
        of_IN hospitalization_NN ._.
        Ecologic_NNP studies_NNS ,_, based_VBN on_IN US_NNP census_NN data_NNS ,_, have_VBP
        demonstrated_VBN a_DT strong_JJ inverse_NN relationship_NN between_IN median_JJ
        household_NN income_NN and_CC hospitalization_NN rates_NNS for_IN asthma_NN [_NN 4_CD ,_,
        5_CD ,_, 6_CD ,_, 15_CD ,_, 16_CD ]_NN ._. Adults_NNS with_IN asthma_NN who_WP live_VBP in_IN lower_JJR income_NN
        geographic_JJ regions_NNS have_VBP higher_JJR rates_NNS of_IN asthma_NN
        hospitalization_NN ,_, even_RB after_IN accounting_VBG for_IN race_NN and_CC
        urbanicity_NN [_NN 5_CD ]_NN ._. Investigators_NNS have_VBP also_RB observed_VBN a_DT similar_JJ
        association_NN between_IN community_NN income_NN level_NN and_CC mortality_NN
        from_IN adult_NN asthma_NN [_NN 33_CD ,_, 34_CD ,_, 35_CD ]_NN ._. Since_IN these_DT studies_NNS lack_VBP
        individual-level_JJ income_NN data_NNS ,_, investigators_NNS have_VBP urged_VBN
        cautious_JJ interpretation_NN [_NN 6_CD ]_NN ._. The_DT present_JJ study_NN ,_, using_VBG
        individual_JJ level_NN data_NNS ,_, supports_VBZ the_DT association_NN between_IN
        lower_JJR household_NN income_NN and_CC a_DT greater_JJR risk_NN of_IN
        hospitalization_NN ._. The_DT relationship_NN between_IN lower_JJR income_NN and_CC
        hospitalization_NN is_VBZ less_RBR strong_JJ in_IN the_DT model_NN including_VBG
        asthma_NN severity_NN and_CC health_NN status_NN ,_, suggesting_VBG that_IN greater_JJR
        asthma_NN severity_NN may_MD mediate_VB this_DT association_NN ._.
        The_DT relationship_NN between_IN low_JJ income_NN and_CC asthma_NN
        hospitalization_NN has_VBZ many_JJ potential_JJ explanations_NNS ,_, including_VBG
        inadequate_JJ health_NN care_NN access_NN ._. Low_NNP income_NN persons_NNS in_IN a_DT
        population-based_JJ survey_NN were_VBD approximately_RB three_CD times_NNS more_RBR
        likely_JJ to_TO report_VB difficulty_NN paying_VBG for_IN physician_NN bills_NNS or_CC
        prescription_NN drugs_NNS than_IN those_DT persons_NNS with_IN higher_JJR income_NN [_NN
        36_CD ]_NN ._. Among_IN adults_NNS hospitalized_VBN for_IN asthma_NN at_IN a_DT single_JJ
        institution_NN ,_, nearly_RB one-third_NN of_IN low_JJ income_NN subjects_NNS
        indicated_VBD no_DT usual_JJ source_NN of_IN outpatient_NN asthma_NN care_NN at_IN
        3_CD -_: month_NN follow-up_JJ [_NN 14_CD ]_NN ._. In_IN the_DT present_JJ study_NN ,_, however_RB ,_,
        nearly_RB all_DT subjects_NNS reported_VBD health_NN insurance_NN and_CC access_NN to_TO
        ambulatory_JJ care_NN for_IN asthma_NN ,_, making_VBG this_DT an_DT unlikely_JJ
        explanation_NN ._. Moreover_RB ,_, excluding_VBG subjects_NNS without_IN baseline_NN
        health_NN insurance_NN coverage_NN had_VBD no_DT appreciable_JJ affect_NN on_IN the_DT
        results_NNS ._.
        Beyond_IN health_NN care_NN access_NN ,_, the_DT process_NN of_IN asthma_NN care_NN
        may_MD be_VB less_RBR adequate_JJ among_IN low_JJ income_NN persons_NNS ._. Haas_NNP 
        et_CC al_NN found_VBD that_IN ,_, after_IN admission_NN to_TO
        the_DT hospital_NN for_IN asthma_NN ,_, low_JJ income_NN patients_NNS received_VBD lower_JJR
        intensity_NN asthma_NN management_NN than_IN those_DT patients_NNS with_IN higher_JJR
        income_NN [_NN 14_CD ]_NN ._. Another_DT study_NN demonstrated_VBD an_DT association_NN
        between_IN a_DT surrogate_JJ marker_NN of_IN low_JJ income_NN (_( unemployment_NN )_) and_CC
        high_JJ daily_JJ beta_NN agonist_NN use_NN [_NN 20_CD ]_NN ,_, which_WDT is_VBZ an_DT established_VBN
        risk_NN factor_NN for_IN asthma_NN hospitalization_NN [_NN 37_CD ]_NN ._. In_IN a_DT managed_VBN
        care_NN setting_NN ,_, which_WDT should_MD ensure_VB health_NN care_NN access_NN ,_, low_JJ
        income_NN asthma_NN patients_NNS were_VBD less_RBR likely_JJ to_TO visit_VB an_DT asthma_NN
        specialist_NN [_NN 10_CD ]_NN ._. Low_NNP income_NN may_MD alternatively_RB be_VB a_DT marker_NN
        for_IN other_JJ exacerbating_VBG factors_NNS ,_, such_JJ as_IN cockroach_NN antigen_NN
        exposure_NN [_NN 6_CD ,_, 38_CD ]_NN ,_, cigarette_NN smoking_NN ,_, secondhand_NN smoke_NN
        exposure_NN [_NN 39_CD ]_NN ,_, or_CC viral_JJ upper_JJ respiratory_JJ infections_NNS ._.
        African-_NNP American_JJ race_NN has_VBZ been_VBN associated_VBN with_IN higher_JJR
        hospitalization_NN rates_NNS for_IN asthma_NN in_IN both_DT population-based_JJ [_NN
        2_CD ]_NN and_CC ecologic_JJ studies_NNS [_NN 4_CD ,_, 5_CD ,_, 6_CD ,_, 7_CD ,_, 15_CD ,_, 16_CD ]_NN ._.
        Socioeconomic_NNP status_NN and_CC health_NN care_NN access_NN ,_, however_RB ,_, may_MD
        confound_NN the_DT relationship_NN between_IN race_NN and_CC hospitalization_NN ._.
        Several_JJ small-area_JJ analyses_NNS found_VBD higher_JJR asthma_NN
        hospitalizations_NNS rates_NNS among_IN African-_NNP Americans_NNPS ,_, after_IN
        statistically_RB controlling_VBG for_IN income_NN [_NN 4_CD ,_, 5_CD ,_, 15_CD ]_NN ._. Other_JJ
        analyses_NNS have_VBP found_VBN no_DT effect_NN of_IN race_NN ,_, after_IN taking_VBG income_NN
        into_IN account_NN [_NN 11_CD ]_NN ._. In_IN children_NNS with_IN access_NN to_TO health_NN care_NN
        through_IN Medicaid_NNP ,_, investigators_NNS still_RB observed_VBD higher_JJR
        hospitalization_NN rates_NNS for_IN African-_NNP Americans_NNPS with_IN asthma_NN [_NN
        13_CD ]_NN ._. African-_NNP American_JJ asthma_NN patients_NNS similarly_RB had_VBD a_DT
        greater_JJR risk_NN of_IN hospitalization_NN for_IN asthma_NN in_IN managed_VBN care_NN
        settings_NNS with_IN access_NN to_TO primary_JJ care_NN [_NN 10_CD ,_, 20_CD ]_NN ._. Even_RB after_IN
        taking_VBG insurance_NN status_NN into_IN account_NN ,_, a_DT national_JJ survey_NN
        found_VBD a_DT higher_JJR proportion_NN of_IN African-_NNP Americans_NNPS reporting_VBG
        difficulty_NN affording_VBG medical_JJ care_NN than_IN that_DT of_IN whites_NNS [_NN
        36_CD ]_NN ._. Our_PRP$ study_NN suggests_VBZ that_IN the_DT increased_VBN risk_NN of_IN
        hospitalization_NN for_IN asthma_NN among_IN African-_NNP Americans_NNPS is_VBZ not_RB
        entirely_RB explained_VBN by_IN income_NN ,_, education_NN ,_, or_CC health_NN care_NN
        access_NN ,_, which_WDT were_VBD controlled_VBN by_IN design_NN or_CC analysis_NN ._.
        We_PRP also_RB discovered_VBD a_DT suggestion_NN that_IN persons_NNS of_IN Hispanic_JJ
        race_NN or_CC ethnicity_NN had_VBD a_DT higher_JJR risk_NN of_IN hospitalization_NN for_IN
        asthma_NN compared_VBN with_IN white_JJ ,_, non-_NN Hispanic_JJ adults_NNS ._. Previous_JJ
        studies_NNS focusing_VBG on_IN Hispanic_JJ persons_NNS have_VBP provided_VBN
        inconsistent_JJ findings_NNS ._. Studies_NNS from_IN New_NNP York_NNP City_NNP and_CC
        Boston_NNP indicate_VBP that_IN Hispanic_JJ persons_NNS are_VBP hospitalized_VBN more_RBR
        frequently_RB for_IN asthma_NN [_NN 4_CD ,_, 6_CD ]_NN ,_, whereas_IN previous_JJ data_NNS from_IN
        California_NNP have_VBP not_RB found_VBN an_DT increased_VBN risk_NN [_NN 5_CD ]_NN ._. Other_JJ
        studies_NNS have_VBP demonstrated_VBN a_DT decreased_VBN morbidity_NN and_CC
        mortality_NN from_IN asthma_NN among_IN Hispanic_JJ adults_NNS [_NN 40_CD ,_, 41_CD ,_, 42_CD ]_NN ._.
        The_DT heterogeneity_NN of_IN persons_NNS of_IN Hispanic_JJ race_NN or_CC ethnicity_NN
        may_MD explain_VB these_DT variable_JJ results_NNS ._.
        Higher_JJR severity-of-asthma_JJ scores_NNS were_VBD associated_VBN with_IN a_DT
        greater_JJR risk_NN of_IN hospitalization_NN for_IN asthma_NN ._. On_IN examining_VBG
        disease-specific_JJ severity_NN in_IN more_JJR detail_NN ,_, we_PRP found_VBD that_IN
        recent_JJ asthma_NN hospitalizations_NNS and_CC systemic_JJ corticosteroid_NN
        use_NN accounted_VBD for_IN most_JJS of_IN this_DT increased_JJ risk_NN ,_, whereas_IN
        recent_JJ respiratory_JJ symptoms_NNS and_CC other_JJ asthma_NN medication_NN use_NN
        were_VBD not_RB predictive_JJ ._. In_IN a_DT recent_JJ analysis_NN of_IN adult_NN health_NN
        maintenance_NN organization_NN members_NNS with_IN asthma_NN ,_, systemic_JJ
        steroid_NN use_NN and_CC previous_JJ hospitalization_NN were_VBD also_RB
        associated_VBN with_IN greater_JJR risk_NN of_IN hospitalization_NN [_NN 21_CD ]_NN ._. A_DT
        study_NN of_IN hospitalized_VBN asthma_NN patients_NNS similarly_RB found_VBD that_IN
        both_DT factors_NNS were_VBD related_VBN to_TO rehospitalization_NN [_NN 43_CD ]_NN ._.
        Neither_DT study_NN ,_, however_RB ,_, controlled_VBN for_IN sociodemographic_JJ
        characteristics_NNS ,_, such_JJ as_IN low_JJ income_NN ,_, that_WDT are_VBP associated_VBN
        with_IN hospitalization_NN risk_NN ._. In_IN the_DT present_JJ study_NN ,_,
        disease-specific_JJ severity_NN was_VBD associated_VBN with_IN a_DT greater_JJR
        risk_NN of_IN hospitalization_NN ,_, controlling_VBG for_IN other_JJ demographic_JJ ,_,
        clinical_JJ ,_, and_CC health_NN care_NN access_NN factors_NNS ._.
        Our_PRP$ findings_NNS differ_VBP from_IN previous_JJ studies_NNS that_WDT found_VBD
        female_JJ gender_NN and_CC current_JJ smoking_NN as_IN risk_NN factors_NNS for_IN
        asthma_NN hospitalization_NN [_NN 9_CD ,_, 39_CD ]_NN ._. Female_NNP gender_NN has_VBZ not_RB
        consistently_RB been_VBN related_VBN to_TO hospitalization_NN for_IN asthma_NN [_NN
        44_CD ]_NN ._. The_DT lack_NN of_IN association_NN with_IN smoking_NN could_MD be_VB
        explained_VBN by_IN the_NNP '_POS healthy_JJ smoker_NN effect_NN '_'' [_NN 45_CD ]_NN ._. According_VBG
        to_TO this_DT principle_NN ,_, persons_NNS who_WP develop_VBP smoking-related_JJ
        respiratory_JJ symptoms_NNS quit_VBD smoking_VBG ,_, resulting_VBG in_IN current_JJ
        smokers_NNS who_WP are_VBP less_RBR susceptible_JJ to_TO acute_JJ effects_NNS of_IN
        smoking_NN ._.
        Previous_JJ studies_NNS evaluating_VBG the_DT effect_NN of_IN GERD_NNP on_IN asthma_NN
        morbidity_NN have_VBP provided_VBN mixed_JJ results_NNS [_NN 46_CD ,_, 47_CD ]_NN ._. In_IN the_DT
        present_JJ study_NN ,_, use_NN of_IN gastric_JJ acid_NN suppression_NN therapy_NN ,_, a_DT
        potential_JJ surrogate_NN for_IN GERD_NNP ,_, was_VBD associated_VBN with_IN a_DT greater_JJR
        risk_NN of_IN asthma_NN hospitalization_NN only_RB in_IN multivariate_NN
        analysis_NN that_WDT did_VBD not_RB control_VB for_IN asthma_NN severity_NN ._. This_DT
        suggests_VBZ that_WDT increased_VBD asthma_NN severity_NN may_MD function_VB as_IN a_DT
        causal_NN intermediate_JJ between_IN GERD_NNP (_( or_CC related_VBN conditions_NNS )_)
        and_CC the_DT increased_VBN likelihood_NN of_IN hospitalization_NN for_IN asthma_NN ._.
        Consistent_NNP with_IN this_DT finding_NN ,_, Levin_NNP 
        et_CC al_NN found_VBD that_DT treatment_NN of_IN GERD_NNP
        with_IN omeprazole_NN improved_VBD asthma-specific_JJ quality_NN of_IN life_NN [_NN
        30_CD ]_NN ._.
        Because_IN adults_NNS with_IN asthma_NN treated_VBN by_IN specialists_NNS
        usually_RB have_VBP more_RBR severe_JJ asthma_NN than_IN those_DT treated_VBN by_IN
        generalist_NN physicians_NNS [_NN 25_CD ]_NN ,_, our_PRP$ study_NN results_NNS should_MD be_VB
        generalized_JJ to_TO the_DT overall_JJ population_NN of_IN asthmatic_JJ persons_NNS
        with_IN caution_NN ._. Although_IN our_PRP$ sampling_VBG method_NN attenuates_NNS
        confounding_VBG by_IN access_NN to_TO medical_JJ care_NN for_IN asthma_NN ,_, the_DT
        results_NNS may_MD not_RB fully_RB apply_VB to_TO populations_NNS without_IN health_NN
        care_NN access_NN ._. Also_RB reflecting_VBG the_DT sampling_VBG from_IN specialty_NN
        practices_NNS ,_, study_NN subjects_NNS had_VBD a_DT higher_JJR median_JJ household_NN
        income_NN and_CC educational_JJ attainment_NN than_IN the_DT general_JJ
        population_NN ._. Even_RB so_RB ,_, low_JJ income_NN was_VBD a_DT risk_NN factor_NN for_IN
        asthma_NN hospitalization_NN ,_, suggesting_VBG that_IN our_PRP$ findings_NNS may_MD be_VB
        more_RBR broadly_RB applicable_JJ ._.
        The_DT present_JJ study_NN has_VBZ additional_JJ limitations_NNS ,_, including_VBG
        the_DT reliance_NN on_IN self-reported_JJ health_NN care_NN utilization_NN ._.
        Socioeconomic_NNP differences_NNS in_IN recall_NN or_CC reporting_NN of_IN
        hospitalization_NN ,_, for_IN instance_NN ,_, could_MD influence_VB the_DT risk_NN
        model_NN ._. Although_IN we_PRP were_VBD able_JJ to_TO simultaneously_RB consider_VB
        demographic_JJ ,_, clinical_JJ ,_, and_CC severity-related_JJ covariates_NNS ,_, the_DT
        current_JJ study_NN does_VBZ not_RB fully_RB elucidate_NN the_DT causal_NN
        intermediates_NNS between_IN predictors_NNS (_( eg_NN income_NN or_CC race_NN )_) and_CC
        the_DT risk_NN of_IN hospitalization_NN ._. Finally_RB ,_, our_PRP$ use_NN of_IN
        self-reported_JJ health_NN insurance_NN status_NN and_CC source_NN of_IN regular_JJ
        asthma_NN care_NN may_MD not_RB fully_RB ascertain_VB other_JJ ,_, more_RBR subtle_JJ ,_,
        barriers_NNS to_TO effective_JJ asthma_NN care_NN ._. Previous_JJ work_NN has_VBZ
        demonstrated_VBN that_DT health_NN insurance_NN status_NN does_VBZ not_RB fully_RB
        explain_VB health_NN care-related_JJ financial_JJ problems_NNS [_NN 36_CD ]_NN ._.
        Transportation_NN difficulties_NNS ,_, work-related_JJ demands_NNS ,_, and_CC
        regional_JJ differences_NNS in_IN health_NN care_NN quality_NN may_MD also_RB have_VB
        impeded_VBN access_NN to_TO efficacious_JJ asthma_NN care_NN ._. Despite_IN these_DT
        limitations_NNS ,_, we_PRP believe_VBP the_DT present_JJ study_NN results_NNS may_MD be_VB
        generalized_JJ to_TO persons_NNS with_IN moderate_JJ to_TO severe_JJ asthma_NN ._.
      
      
        Conclusion_NNP
        Although_IN the_DT morbidity_NN and_CC mortality_NN from_IN asthma_NN are_VBP
        increasing_VBG in_IN the_DT USA_NNP and_CC around_IN the_DT world_NN ,_, the_DT minority_NN of_IN
        adults_NNS with_IN asthma_NN will_MD experience_VB hospitalization_NN or_CC death_NN
        from_IN asthma_NN ._. Targeted_NNP interventions_NNS could_MD potentially_RB
        benefit_VB high-risk_JJ individuals_NNS in_IN a_DT cost-effective_JJ manner_NN ._.
        Our_PRP$ results_NNS suggest_VBP that_IN simple_JJ demographic_JJ and_CC clinical_JJ
        features_NNS ,_, especially_RB low_JJ income_NN ,_, non-white_JJ race_NN ,_, previous_JJ
        hospitalization_NN history_NN ,_, systemic_JJ corticosteroid_NN use_NN ,_, and_CC
        reliance_NN on_IN emergency_NN department_NN for_IN urgent_JJ asthma_NN care_NN ,_,
        can_MD identify_VB such_JJ high-risk_JJ patients_NNS for_IN more_RBR intensive_JJ
        therapy_NN ._.
      
      
        Supplementary_NNP material_NN
        
          Subject_NNP recruitment_NN and_CC retention_NN
          In_IN brief_JJ ,_, we_PRP recruited_VBD a_DT random_JJ sample_NN of_IN certified_VBN
          American_NNP Board_NNP of_IN Medical_NNP Specialty_NNP pulmonary_JJ specialists_NNS
          and_CC allergy_NN /_NN immunology_NN specialists_NNS ._. The_DT participating_VBG
          physicians_NNS maintained_VBD a_DT registry_NN of_IN persons_NNS aged_VBN 18_CD -_: 50_CD
          years_NNS with_IN outpatient_NN visits_NNS for_IN asthma_NN over_IN a_DT
          prospective_JJ 4_CD -_: week_NN period_NN ._. Each_DT person_NN registered_VBN by_IN a_DT
          participating_VBG physician_NN was_VBD contacted_VBN to_TO arrange_VB a_DT
          telephone_NN interview_NN ._.
        
        
          Risk_NN factor_NN variables_NNS
          We_PRP ascertained_JJ household_NN income_NN as_IN a_DT series_NN of_IN
          increments_NNS (_( less_JJR than_IN $_$ 5000_CD ,_, $_$ 5001_CD -_: $_$ 10_CD ,_, 000_CD ,_, $_$ 10_CD ,_, 000_CD
          increments_NNS up_IN to_TO $_$ 50_CD ,_, 000_CD ,_, $_$ 50_CD ,_, 001_CD -_: $_$ 75_CD ,_, 000_CD ,_, and_CC above_RB
          $_$ 75_CD ,_, 000_CD )_) ._. To_TO convert_VB to_TO specific_JJ income_NN levels_NNS ,_, the_DT
          mid-increment_JJ value_NN was_VBD applied_VBN (_( except_IN for_IN the_DT highest_JJS
          category_NN ,_, where_WRB we_PRP used_VBD a_DT value_NN of_IN $_$ 87_CD ,_, 500_CD )_) ._.
          The_DT severity-of-asthma_JJ score_NN systemic_JJ corticosteroid_NN
          sub-scale_JJ includes_VBZ items_NNS for_IN any_DT past_JJ corticosteroid_NN use_NN ,_,
          use_NN during_IN the_DT past_JJ 12_CD months_NNS ,_, and_CC steroid_NN dependency_NN ._.
          The_DT asthma_NN medication_NN subscale_NN incorporates_VBZ current_JJ use_NN
          of_IN inhaled_JJ corticosteroids_NNS ,_, inhaled_JJ non-steroidal_JJ
          anti-inflammatory_JJ agents_NNS ,_, inhaled_JJ bronchodilators_NNS ,_, oral_JJ
          beta_NN agonists_NNS and_CC theophylline-containing_JJ medications_NNS ,_,
          nasal_NN medications_NNS (_( antihistamines_NNS ,_, decongestants_NNS ,_, and_CC
          topical_JJ corticosteroids_NNS )_) ,_, and_CC home_NN nebulizer_NN use_NN ._. In_IN this_DT
          subscale_NN ,_, one_CD point_NN is_VBZ assigned_VBN for_IN each_DT medication_NN used_VBN
          during_IN the_DT past_JJ 2_CD weeks_NNS ,_, with_IN one_CD additional_JJ point_NN for_IN
          frequent_JJ inhaled_JJ beta_NN agonist_NN or_CC corticosteroid_NN use_NN ._.
          We_PRP measured_VBD generic_JJ health_NN status_NN using_VBG the_DT Medical_NNP
          Outcomes_NNP Study_NNP SF-_NNP 36_CD questionnaire_NN ._. Previous_JJ work_NN
          demonstrates_VBZ the_DT SF-_NNP 36_CD instrument_NN 's_POS validity_NN in_IN adult_NN
          asthma_NN [_NN 31_CD ]_NN ._. The_DT physical_JJ and_CC mental_JJ component_NN summary_NN
          scores_NNS have_VBP been_VBN defined_VBN from_IN the_DT eight_CD SF-_NNP 36_CD subscales_NNS
          by_IN factor_NN analysis_NN [_NN 32_CD ]_NN ,_, which_WDT measure_NN physical_JJ and_CC
          mental_JJ dimensions_NNS of_IN health_NN ,_, respectively_RB ._. Each_DT summary_NN
          score_NN in_IN the_DT general_JJ US_NNP population_NN has_VBZ a_DT mean_NN of_IN 50_CD and_CC a_DT
          standard_JJ deviation_NN of_IN 10_CD ._. Higher_JJR scores_NNS reflect_VBP more_RBR
          favorable_JJ health_NN states_NNS ._.
        
      
    
  
